Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.21.1
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Revenue $ 51 $ 28
Operating expenses:    
Costs of revenue - sales 28 30
Research and development 1,345 1,935
Sales and marketing 676 1,863
General and administrative 2,444 2,912
Total costs and expenses 4,493 6,740
Operating loss (4,442) (6,712)
Gain (loss) on change in estimated fair value of contingent royalty obligation (80) 321
Finance expense, net (117) (112)
Foreign currency loss (10) (8)
Net loss (4,649) (6,511)
Deemed dividends from warrant issuance (6,145)  
Net loss attributable to common shareholders $ (10,794) $ (6,511)
Basic and diluted loss per common share:    
Net loss (in Dollars per share) $ (0.11) $ (0.23)
Net loss attributable to common shareholders (in Dollars per share) $ (0.25) $ (0.23)
Weighted average number of common shares outstanding, basic and diluted (in Shares) 42,230,001 28,817,711